2010/12/12

Atrican 250

Release form, composition and packing

Enteric soft gelatin capsule, opaque, ovoid, yellow-brown, measuring about 7.5 mm x 14 mm; contents of capsules - gray-brown homogeneous oily mass.

1 capsule. tenonitrozol 250 mg.

Other ingredients: peanut butter, hydrogenated soybean oil, soy lecithin, gelatin, sorbitol and sorbitanov solution, glycerol, hypromellose phthalate, dibutyl phthalate, titanium dioxide (E171), iron oxide yellow (E172).

Clinico-pharmacological group: Protivoprotozoyny drug used for trichomoniasis.

Pharmacological action

Protivoprotozoyny drug. Active against Trichomonas vaginalis. Has also disulfiramopodobnoe action.

Pharmacokinetics

Absorption and excretion

Well absorbed from the gastrointestinal tract. Slowly excreted, thus maintaining the blood concentration trihomonatsidnuyu for many hours.

Statement
trichomoniasis of the urogenital system.

Dosing regimen

The drug was appointed interior, 250 mg 2 times a day (morning and evening) during the meal for 4 days. Do not exceed the recommended daily dose. In the case of pass the admission of one or more doses of the drug should be resumed in the usual dose.

Side effect
From the digestive system: sometimes - nausea, feeling of heaviness in the epigastrium, loss of appetite.

Other: allergic reactions.

Contraindications
acute and chronic liver failure;
Infancy;
Hypersensitivity to tenonitrozolu and other ingredients.

Pregnancy and lactation

It is advisable not to use the drug during pregnancy. Do not recommend to use the drug during lactation (breastfeeding) because tenonitrozol excreted in breast milk.

Use in hepatic dysfunction

Contraindicated in acute and chronic liver failure.

Cautions

The drug is used to treat trichomoniasis only in adults. During treatment you should avoid alcohol and drugs containing ethanol.

Should not be prescribed medication to persons who are not able to abstain from alcohol during treatment. Necessary to carry out the simultaneous treatment of sexual partners. Not recommended to wear contact lenses during treatment with Atrikan 250 (possibly penetration of the active substance in the eye fluid).

In applying Atrikana 250 possible color sclera and urine yellow. The patient should be informed about the need to tell the doctor about a history of episodes of change in the number of leukocytes in peripheral blood while taking other medicines.

Overdose

Currently, cases of drug overdose Atrikan 250 is not reported.

Drug Interactions

Keep in mind that during the period of the drug is contraindicated in receiving ethanol. Conditions and terms of List B. The drug should be stored in a dry place inaccessible to children at or above 30 ° C.

Shelf life - 3 years.

No comments:

Post a Comment